Association of p53 with Bid Induces Cell Death in Response to Etoposide Treatment in Hepatocellular Carcinoma

E-ISSN： 1873-5576|9|7|871-880

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.9, Iss.7, 2009-11, pp. : 871-880

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel histone deacetylase inhibitor CG200745 induces clonogenic cell death by modulating acetylation of p53 in cancer cells

By Oh Eun-Taex

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 435-442

Springer Publishing Company

Access to resources Recommend Favorite

Association of Programmed Cell Death Factor 4 (PDCD4) with Hepatocellular Carcinoma and Smoking in a Chinese Male Population

By Jiang Y Zhang SH-H Han G-Q Qin CH-Y

The Journal of International Medical Research, Vol. 37, Iss. 4, 2009-07 ,pp. : 1179-1183

Field House Publishing

Access to resources Recommend Favorite

FHIT and p53 Status and Response to Platinum-Based Treatment in Advanced Non-Small Cell Lung Cancer

Current Cancer Drug Targets, Vol. 8, Iss. 5, 2008-08 ,pp. : 342-348

Bentham Science Publishers

Access to resources Recommend Favorite

Nutlin-3, A p53-Mdm2 Antagonist for Nasopharyngeal Carcinoma Treatment

Mini Reviews in Medicinal Chemistry, Vol. 18, Iss. 2, 2018-01 ,pp. : 173-183

Bentham Science Publishers

Access to resources Recommend Favorite

Acrolein induces apoptosis through the death receptor pathway in A549 lung cells: role of p53

By Roy Julie Pallepati Pragathi Bettaieb Ahmed Averill-Bates Diana A.

Canadian Journal of Physiology and Pharmacology, Vol. 88, Iss. 3, 2010-03 ,pp. : 353-368

NRC Research Press

Access to resources Recommend Favorite